Supramolecular PEGylation of biopharmaceuticals

Supramolecular PEGylation of biopharmaceuticals

The covalent modification of therapeutic biomolecules has been broadly explored, leading to a number of clinically approved modified protein drugs. These modifications are typically intended to address challenges arising in biopharmaceutical practice by promoting improved stability and shelf life of...

Full description

Bibliographic Details
Main Authors: Vinciguerra, Brittany (Author), Thapa, Lavanya S. (Author), Jhunjhunwala, Siddharth (Author), Isaacs, Lyle (Author), Webber, Matthew (Contributor), Appel, Eric (Contributor), Cortinas, Abel Bryan (Contributor), Langer, Robert S (Contributor), Anderson, Daniel Griffith (Contributor)
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science (Contributor), Harvard University- (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: National Academy of Sciences (U.S.), 2017-09-13T20:03:38Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items